Inner conflict in patients receiving oral anticancer agents: a qualitative study

Kaori Yagasaki; Hiroko Komatsu; Tsunehiro Takahashi
April 2015
BMJ Open;Apr2015, Vol. 5 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center. Chan, Alexandre; Leow, Yumei Cynthia; Mui Hian Sim // Journal of Oncology Pharmacy Practice;Sep2009, Vol. 15 Issue 3, p161 

    Background. In view of the increased usage of oral anticancer drugs in the contemporary treatment of cancer, we aimed to examine cancer patients' perspectives of oral anticancer drugs, through a survey at an Asian cancer centre. This study also intended to describe patients' behavior regarding...

  • Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada. Abbott, Rick; Edwards, Scott; Whelan, Maria; Edwards, Jonathan; Dranitsaris, George // Journal of Oncology Pharmacy Practice;Feb2014, Vol. 20 Issue 1, p29 

    Purpose: Oral anticancer agents offer significant benefits over parenteral anticancer therapy in terms of patient convenience and reduced intrusiveness. Oral anticancer agents give many cancer patients freedom from numerous hospital visits, allowing them to obtain their medications from their...

  • Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial. Hiroko Komatsu; Kaori Yagasaki; Takuhiro Yamaguchi // BMC Nursing;2/8/2016, Vol. 15, p1 

    Background: With the widespread use of orally administered anticancer agents, self-management by cancer patients is inevitable, and adherence to medication is becoming the centre of interest in oncology. Methods/Design: This mixed-method study is a two-phased approach with a combined...

  • Implementation of and Satisfaction with an Outpatient Oral Anticancer Therapy Program. Koselke, Elizabeth A.; Marini, Bernard L.; Kraft, Shawna L.; Walker, Suzette C.; Allore, Dawna D.; Mackler, Emily R. // Journal of Hematology Oncology Pharmacy;Sep2015, Vol. 5 Issue 3, p62 

    Background: The use of oral medications in cancer treatment has increased considerably the past several years with the ongoing development of novel oral anticancer agents. Although the rapid implementation of oral anticancer agents into practice has been widely adapted, there are numerous...

  • Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Olver, Ian; Clark-Snow, Rebecca; Ballatori, Enzo; Espersen, Birgitte; Bria, Emilio; Jordan, Karin // Supportive Care in Cancer;Mar2011, Vol. 19, p33 

    Purpose: The purpose of this study is to update the guidelines for antiemetic therapy to be used with anticancer agents of low to minimal emetic potential. Methods: Experts from the Multinational Association of Supportive Care in Cancer (MASCC) met in Perugia in 2009 to revise the MASCC...

  • Oral Anticancer Agents. Spoelstra, Sandra L.; Sikorskii, Alla; Majumder, Atreyee; Burhenn, Peggy S.; Schueller, Monica; Given, Barbara // Clinical Journal of Oncology Nursing;Apr2017, Vol. 21 Issue 2, p157 

    Symptom burden and poor adherence to oral anticancer agents remain significant clinical problems. This study examined feasibility, preliminary efficacy, and satisfaction with ADHERE, a nurse practitioner intervention that promotes symptom management and adherence among patients prescribed oral...

  • Oral anti-cancer agents in the community setting: A survey of pharmacists in Newfoundland and Labrador. Abbott, Rick; Edwards, Scott; Edwards, Jonathan; Dranitsaris, George // Canadian Pharmacists Journal (Allen Press Publishing Services In;Sep/Oct2011, Vol. 144 Issue 5, p220 

    The article presents a study on the oral administration of anti-cancer agents for disease control in Newfoundland and Labrador. It states that the increase in the use oral anti-cancer agents (OAAs) raises concerns that community pharmacists may not have the training to safely dispense these...

  • ANTINEOPLASTONS SHOW PROMISE IN PRELIMINARY STUDIES.  // Life Extension;May2004, Vol. 10 Issue 5, p81 

    Reports that natural anticancer agent antineoplastons show promise for cancer treatment in preliminary studies. Progress of patients who received antineoplaston therapy; Different results of antineosplaston therapy in diffeernt types of cancer

  • Oral cancer treatment: developments in chemotherapy and beyond. O'Neill, V.J.; Twelves, C.J. // British Journal of Cancer;10/21/2002, Vol. 87 Issue 9, p933 

    Oncology is one of the few areas of medicine where most patients are treated intravenously rather than receiving oral drugs. Recently, several oral anti-cancer drugs nave been approved and there are many more in development. Oral chemotherapy is attractive because of its convenience and ease of...

  • Capecitabine.  // Reactions Weekly;Feb2015, Vol. 1540 Issue 1, p79 

    The article presents a case study of a patient who died of pancytopenia, which developed while receiving capecitabine, an orally-administered chemotherapeutic agent for the treatment of cancer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics